Advertisement
Advertisement

MBIO

MBIO logo

Mustang Bio, Inc.

0.59
USD
Sponsored
-0.01
-1.76%
Aug 10, 15:58 UTC -4
Closed
exchange

After-Market

0.60

+0.01
+2.52%

Mustang Bio, Inc. Profile

About

Mustang Bio, Inc. a subsidiary of Fortress Biotech, Inc., is a clinical?stage biopharmaceutical company. It focused on the development and commercialization of novel cancer immunotherapy products designed to leverage the patient's own immune system to eliminate cancer cells. Mustang Bio, Inc. is based in New York, United States.

Info & Links

CEO

Manuel Litchman

Headquarters

95 SAWYER ROAD, SUITE 110
WALTHAM, MA 02453, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.mustangbio.com

Auditor

KPMG LLP

Share holders

57

Employees

4

Mustang Bio, Inc. Statistics

Valuation Measures

Market Capitalization2

4.58M

Enterprise Value

-10.57M

Enterprise Value/EBITDA(ttm)

3.00

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.60

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-34.23%

Return on Invested Capital(ttm)

-35.75%

Return on Assets(ttm)

-17.55%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-3.52M

Net Income Available to Common(ttm)

-3.03M

Diluted EPS(ttm)

-0.45

Share Statistics

Beta (5Y Monthly)

2.06

52-Week Change

-64.45%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

7.58M

Dividend Yield

0.00%

Float4

7.27M

% Held by Insiders

4.00%

% Held by Institutions

9.95%

Balance Sheet

Total Cash(mrq)

15.15M

Total Cash Per Share(mrq)

2.00

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.97%

Quick Ratio(mrq)

1.97%

Book Value Per Share(mrq)

1.00

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.29

Free Cash Flow(ytd)

-1.98M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement